Literature DB >> 12361952

Defining the importance of phosphatidylserine synthase 2 in mice.

Martin O Bergo1, Bryant J Gavino, Rineke Steenbergen, Benedicte Sturbois, Albert F Parlow, David A Sanan, William C Skarnes, Jean E Vance, Stephen G Young.   

Abstract

Phosphatidylserine synthase 1 (Pss1) and phosphatidylserine synthase 2 (Pss2) produce phosphatidylserine by exchanging serine for the head groups of other phospholipids. Pss1 and Pss2 are structurally similar (approximately 32% amino acid identity) but differ in their substrate specificities, with Pss1 using phosphatidylcholine for the serine exchange reaction and Pss2 using phosphatidylethanolamine. Whether Pss1 and Pss2 are both required for mammalian growth and development is not known, and no data exist on the relative contributions of the two enzymes to serine exchange activities in different tissues. To address those issues and also to define the cell type-specific expression of Pss2, we generated Pss2-deficient mice in which a beta-galactosidase marker is expressed from Pss2 regulatory sequences. Histologic studies of Pss2-deficient mice revealed very high levels of beta-galactosidase expression in Sertoli cells of the testis and high levels of expression in brown fat, neurons, and myometrium. The ability of testis extracts from Pss2-deficient mice to catalyze serine exchange was reduced by more than 95%; reductions of approximately 90% were noted in the brain and liver. However, we found no perturbations in the phospholipid content of any of these tissues. As judged by Northern blots, the expression of Pss1 was not up-regulated in Pss2-deficient cells and tissues. Testis weight was reduced in Pss2-deficient mice, and some of the male mice were infertile. We conclude that Pss2 is responsible for the majority of serine exchange activity in in vitro assays, but a deficiency in this enzyme does not cause perturbations in phospholipid content or severe developmental abnormalities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361952     DOI: 10.1074/jbc.M207734200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.

Authors:  Sweta Rani; Aideen E Ryan; Matthew D Griffin; Thomas Ritter
Journal:  Mol Ther       Date:  2015-03-19       Impact factor: 11.454

Review 2.  Phosphatidylserine in the brain: metabolism and function.

Authors:  Hee-Yong Kim; Bill X Huang; Arthur A Spector
Journal:  Prog Lipid Res       Date:  2014-06-30       Impact factor: 16.195

3.  Expression profiling reveals meiotic male germ cell mRNAs that are translationally up- and down-regulated.

Authors:  Naoko Iguchi; John W Tobias; Norman B Hecht
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 4.  Lipid metabolism in Trypanosoma brucei.

Authors:  Terry K Smith; Peter Bütikofer
Journal:  Mol Biochem Parasitol       Date:  2010-04-09       Impact factor: 1.759

5.  Gonadal lipidomics profile of an ovoviviparity teleost, black rockfish, during gonadal development.

Authors:  Jianshuang Li; Min Song; Haishen Wen; Ying Zhang; Yun Li; Likang Lyu; Xiaojie Wang; Xin Qi
Journal:  Fish Physiol Biochem       Date:  2021-03-10       Impact factor: 2.794

6.  Physiological consequences of disruption of mammalian phospholipid biosynthetic genes.

Authors:  Dennis E Vance; Jean E Vance
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

7.  An in vivo ratio control mechanism for phospholipid homeostasis: evidence from lipidomic studies.

Authors:  Marcus K Dymond; Charlotte V Hague; Anthony D Postle; George S Attard
Journal:  J R Soc Interface       Date:  2012-12-19       Impact factor: 4.118

8.  ATP-citrate lyase deficiency in the mouse.

Authors:  Anne P Beigneux; Cynthia Kosinski; Bryant Gavino; Jay D Horton; William C Skarnes; Stephen G Young
Journal:  J Biol Chem       Date:  2003-12-08       Impact factor: 5.157

Review 9.  Phosphatidylserine targeting for diagnosis and treatment of human diseases.

Authors:  Kristof Schutters; Chris Reutelingsperger
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

10.  Phosphatidylserine synthase 2: high efficiency for synthesizing phosphatidylserine containing docosahexaenoic acid.

Authors:  Atsuko Kakio Kimura; Hee-Yong Kim
Journal:  J Lipid Res       Date:  2012-10-15       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.